Atefe Abak
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- Circular RNAs in diseases
- RNA modifications and cancer
- Extracellular vesicles in disease
- RNA Research and Splicing
- RNA Interference and Gene Delivery
- Epigenetics and DNA Methylation
Papers in
-
- Cancer-related molecular mechanisms research 30
- MicroRNA in disease regulation 26
-
- Circular RNAs in diseases 17
- RNA modifications and cancer 8
- RNA Interference and Gene Delivery 4
- PI3K/AKT/mTOR signaling in cancer 4
- Cancer-related gene regulation 3
- Co-authors
- Mohammad Taheri (44 shared papers)Soudeh Ghafouri‐Fard (45 shared papers)Hamed Shoorei (27 shared papers)Bashdar Mahmud Hussen (19 shared papers)Alireza Abhari (5 shared papers)Jamal Majidpoor (3 shared papers)Farhad Tondro Anamag (2 shared papers)Abbas Basiri (2 shared papers)
In The Last Decade
Atefe Abak
50 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 101
- Cancer Research 749
- Molecular Biology 888
- Immunology 118
- Oncology 118
- Pathology and Forensic Medicine 68
Countries citing papers authored by Atefe Abak
This map shows the geographic impact of Atefe Abak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atefe Abak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atefe Abak more than expected).
Fields of papers citing papers by Atefe Abak
This network shows the impact of papers produced by Atefe Abak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atefe Abak. The network helps show where Atefe Abak may publish in the future.
Co-authors
The 25 scholars most cited alongside Atefe Abak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 128 | |
| 2 | 2021 | 113 | |
| 3 | 2020 | 73 | |
| 4 | 2021 | 70 | |
| 5 | 2018 | 67 | |
| 6 | 2021 | 61 | |
| 7 | 2020 | 59 | |
| 8 | 2021 | 54 | |
| 9 | 2021 | 54 | |
| 10 | 2021 | 54 | |
| 11 | 2020 | 47 | |
| 12 | 2021 | 45 | |
| 13 | 2021 | 42 | |
| 14 | 2021 | 41 | |
| 15 | 2021 | 39 | |
| 16 | 2021 | 36 | |
| 17 | 2018 | 33 | |
| 18 | 2022 | 32 | |
| 19 | 2021 | 31 | |
| 20 | 2021 | 31 |
About Atefe Abak
Atefe Abak is a scholar working on Cancer Research, Molecular Biology, Oncology, Immunology and Epidemiology, having authored 51 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (30 papers), MicroRNA in disease regulation (26 papers), Circular RNAs in diseases (17 papers), RNA modifications and cancer (8 papers), RNA Interference and Gene Delivery (4 papers), Cytokine Signaling Pathways and Interactions (4 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Cancer-related gene regulation (3 papers). The work is most often cited by research in Cancer Research (749 citations), Molecular Biology (888 citations), Immunology (118 citations), Oncology (118 citations) and Pathology and Forensic Medicine (68 citations). Atefe Abak has collaborated with scholars based in Iran, Iraq and Germany. Frequent co-authors include Mohammad Taheri, Soudeh Ghafouri‐Fard, Hamed Shoorei, Bashdar Mahmud Hussen, Alireza Abhari, Jamal Majidpoor, Farhad Tondro Anamag, Abbas Basiri, Mahdi Mohaqiq and Nader Akbari Dilmaghani. Their work appears in journals such as Biomedicine & Pharmacotherapy, Frontiers in Cell and Developmental Biology, Frontiers in Immunology, Frontiers in Oncology and Cancer Cell International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.